TITLE

HIV Infection: The Role of Primary Care

AUTHOR(S)
ROMANELLI, FRANK; MATHENY, SAMUEL C.
PUB. DATE
November 2009
SOURCE
American Family Physician;11/1/2009, Vol. 80 Issue 9, p946
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Human immunodeficiency virus infection was first documented in the United States in 1981. Since that time, significant strides have been made in the prevention and treatment of the condition. Screening is paramount in identifying early infection and is now a routine component of primary care. Primary care physicians are also often involved in monitoring patients with the infection. Diagnosis can occur at any stage of human immunodeficiency virus infection. The acute retroviral syndrome that occurs shortly after infection is characterized by constitutional symptoms and is often difficult to differentiate from common community-acquired viruses. Appropriate management with combination antiretroviral therapy often extends the patient's life, sometimes for many years. Selection of pharmacotherapy is usually based on genotypic or phenotypic resistance testing. Therapy is lifelong and complicated by pill burden, cost, adverse effects, and drug interactions.
ACCESSION #
45084129

 

Related Articles

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

  • Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel. Yeni, Patrick G.; Hammer, Scott M.; Hirsch, Martin S.; Saag, Michael S.; Schechter, Mauro; Carpenter, Charles C. J.; Fischl, Margaret A.; Gatell, Jose M.; Gazzard, Brian G.; Jacobsen, Donna M.; Katzenstein, David A.; Montaner, Julio S. G.; Richman, Douglas D.; Schooley, Robert T.; Thompson, Melanie A.; Vella, Stefano; Volberding, Paul A. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p251 

    Context Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral management of adults with established HIV infection. Objective To update recommendations for physicians who provide...

  • Metabolic Effects of Rosiglitazone in HIV Lipodystrophy. Hadigan, Colleen; Yawetz, Sigal; Thomas, Abraham; Havers, Fiona; Sax, Paul E.; Grinspoon, Steven // Annals of Internal Medicine;5/18/2004, Vol. 140 Issue 10, p786 

    Background: Patients with HIV infection who are treated with antiretroviral agents often lose subcutaneous fat and have metabolic abnormalities, including insulin resistance and reduced adiponectin levels, which may be related to disrupted subcutaneous adipogenesis and altered peroxisome...

  • In Vitro Inhibitory Effects of the Herbal-Marine Compound HESA-A Against Replication of Human Immunodeficiency Virus-1. Vahabpour, Rouhollah; Sadat, Seyed Mehdi; Zabihollahi, Rezvan; Ahmadi, Amrollah; Keivani, Hossein; Amini, Safieh; Siadat, Seyed Davar; Aghasadeghi, Mohammad Reza // Jundishapur Journal of Microbiology;2012, Vol. 5 Issue 1, p315 

    Background: For more than 2 decades, human immunodeficiency virus (HIV) infection has been known to cause significant morbidity and mortality. Difficulties in treating HIV-infected patients include adverse effects and drug resistance and continue to limit the use of conventional anti-retroviral...

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospital. Rather, Zahoor A.; Chowta, Mukta N.; Prakash Raju, G. J. K.; Mubeen, Faheem // Indian Journal of Pharmacology;Mar/Apr2013, Vol. 45 Issue 2, p145 

    Objectives: Antiretroviral toxicity is an increasingly important issue in the management of HIV-infected patients. The objective of our study was to evaluate the toxicity profile of currently used antiretroviral regimens and to compare these toxicities among males and females. Materials and...

  • Structured Intermittent Therapy with Seven-Day Cycles of HAART for Chronic HIV Infection: A Pilot Study in São Paulo, Brazil. Casseb, Jorge; Da Silva Duarte, Alberto Jos // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p425 

    In the last 6 years, an impressive impact of the highly active antiretroviral therapy (HAART) on survival and morbidity in HIV-1–infected individuals has been attained. However, their prolonged use may induce metabolic adverse effects such as lipodistrophy, hypertension, diabetes...

  • Global patient safety and antiretroviral drug–drug interactions in the resource-limited setting. Seden, Kay; Khoo, Saye H.; Back, David; Byakika-Kibwika, Pauline; Lamorde, Mohammed; Ryan, Mairin; Merry, Concepta // Journal of Antimicrobial Chemotherapy (JAC);Jan2013, Vol. 68 Issue 1, p1 

    Scale-up of HIV treatment services may have contributed to an increase in functional health facilities available in resource-limited settings and an increase in patient use of facilities and retention in care. As more patients are reached with medicines, monitoring patient safety is increasingly...

  • Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study. Monteiro, Polyana; Perez, Iñaki; Pich, Judit; Gatell, Jose Maria; Martínez, Esteban // Journal of Antimicrobial Chemotherapy (JAC);Feb2013, Vol. 68 Issue 2, p404 

    Objectives To evaluate the incidence and risk factors for significant creatine kinase elevation in HIV-1-infected patients who were prescribed a raltegravir-containing antiretroviral therapy. Design A retrospective analysis of a prospectively collected cohort involving all consecutive patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics